KIN - Kindred Biosciences, Inc.
This page shows which of the focused investors we track hold KIN and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2016 it was held by 2 managers with an aggregate reported value of $23.75M, which is 0.00% of the combined portfolio.
As of Q2 2016, 2 tracked institutional managers held KIN (Kindred Biosciences, Inc.) with an aggregate reported value of $23.75M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades KIN — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2016
- Ticker
- KIN
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Ariel Investments - Ariel Investments | 0.16% | Add +3.0% | 3,695,576 | $13.08M |
| 2 | Seth Klarman - Baupost Group | 0.14% | - | 3,013,848 | $10.67M |
Loading holder history for KIN…